GO
Loading...

Why Roche is launching a new investment plan

Monday, 14 Oct 2013 | 11:35 AM ET

Andrew Weiss, head of pharma and biotech research at Vontobel, says Roche's plan reflects the Swiss pharmaceutical giant's strong pipeline.